Skip to main content

Tango Therapeutics, Inc 10-K for FY2024

Tango Therapeutics, Inc. (TNGX)

10-K 2025-02-27 For: 2024-12-31
View Original
Added on April 08, 2026

About this 10-K

Tango Therapeutics, Inc filed this 10-K on February 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$42.07M
up 15.2% from $36.53M a year earlier
Net loss
$130.3M
compared with a net loss of $101.74M a year earlier
Diluted EPS
-$1.19
compared with -$1.08 a year earlier